openPR Logo
Press release

Major Growth Driver Identified in 2025 Biologics Market: Personalized Medicine Fueling Growth In The Biologics Market

07-14-2025 03:07 PM CET | Health & Medicine

Press release from: The Business Research Company

Biologics Market

Biologics Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Biologics Industry Market Size Be by 2025?
The size of the biologics market has witnessed a swift expansion in the past few years. The market is predicted to rise from $533.36 billion in 2024 to $610.25 billion in 2025, indicating a compound annual growth rate (CAGR) of 14.4%. The historical growth could be linked to factors such as the aging population, government policies, the capacity to demand high prices, and growing need for immunology.

What's the Long-Term Growth Forecast for the Biologics Market Size Through 2029?
There is an anticipation of quick expansion in the biologics market in the upcoming years. It is projected to swell to $1068.24 billion by 2029, with a compound annual growth rate (CAGR) of 15.0%. Factors contributing to this growth prediction include increased funding, improvements in technology, broader access to healthcare, vigorous research and development of oral biologics, a preference for pills over injections, and a strong developmental pipeline for biologics. Key trends for the forecast period encompass utilizing updated and relaxed regulations to formulate better biologics, a shift towards biologic drug creation, investment in research and development for unique biologic innovations, and a focus on R&D for biologics aimed at complex diseases' treatment.

View the full report here:
https://www.thebusinessresearchcompany.com/report/biologics-global-market-report

What Are the Key Growth Drivers Fueling the Biologics Market Expansion?
The surge in personalized medicine demand is significantly contributing to the expansion of the global biologics market. Personalized or precision medicine is a healthcare approach that adjusts medical treatment and healthcare according to each patient's unique attributes. It provides the chance to adapt biological treatments to a patient's distinct clinical and genetic profile, revolutionizing the healthcare industry. For example, the Personalized Medicine Coalition, a hospital and health care organization based in the US, reported in February 2024 that the FDA approved 16 new tailored treatments for rare disease patients in 2023, a significant rise from six in 2022. The growing demand for personalized medicine is therefore fostering the growth of the biologics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3606&type=smp

What Are the Key Trends Driving Biologics Market Growth?
Top firms in the biologics sector are concentrating their efforts on the invention of groundbreaking products like oncology biosimilars, in order to solidify their market presence and gain a competitive advantage. Oncology biosimilars are a type of biologic drug used in cancer treatment, which are nearly identical copies of existing biologic drugs. For example, in May 2022, Biocon Biologics Limited, Biocon Limited's subsidiary from India and Viatris Inc., a pharmaceutical company based in the US, introduced Abevmy, an oncology biosimilar, to the Canadian market. Abevmy is a biosimilar medication for cancer treatment. Biosimilar medicines are biological medicines that highly resemble authorized biological medicines. They are used to treat the same diseases as their reference medicines and have identical safety and effectiveness.

How Is the Biologics Market Segmented?
The biologics market covered in this report is segmented -

1) By Type: Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines
2) By Drug Classification: Branded Drugs, Generic Drugs
3) By Route Of Administration: Oral, Other Route Of Administration
4) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies Or Drug Stores, Other Distribution Channels

Subsegments:
1) By Monoclonal Antibodies (MAbs): Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Monoclonal Antibodies
2) By Therapeutic Proteins: Hormones, Enzymes, Cytokines, Fusion Proteins
3) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, mRNA Vaccines, Viral Vector Vaccines

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3606&type=smp

Which Companies Are Leading the Charge in Biologics Market Innovation?
Major companies operating in the biologics market include Merck & Co., Inc., AbbVie Inc., F. Hoffmann-La Roche AG, Johnson & Johnson, Pfizer Inc., Bristol Myers Squibb Company, Sanofi S.A., GlaxoSmithKline Plc., Eli Lilly and Company, Amgen Inc., Wockhardt, Zydus Cadilla, China Biologic Products Holdings Inc., ABLbio, Adimmune, Henlius, Innovent Biologics, Bio-Thera, Hisun Pharma, 3SBio, Beijing ShuangLu Pharmaceuticals, Qilu Pharmaceutical, Biocon, Dr.Reddy's, Mylan, Kyowa Hakko Kirin, Takeda, Mitsubishi Tanabe, AGC Biologics, Tonghua Dongbao Pharmaceutical Co., China Regenerative Medicine International, Shanghai Fosun Pharmaceuticals, Bayer AG, Novartis AG, BiosanaPharma, WuXi, Teva UK Limited, AstraZeneca, Abbott Laboratories, Vectura Group, Fujifilm, Lonza, Seqens, Piramal Pharma Solutions, Corden Pharma, Procos SpA and BSP Pharmaceuticals., Microgen, Geropharm, Valenta, NovaMedica, SynBi, Rani Therapeutics, Enteris BioPharma, Allena Pharmaceuticals, Biogen Inc., Emisphere Technologies Inc., Biogen Inc., Apotex, Gilead Sciences

Which Regions Are Leading the Global Biologics Market in Revenue?
North America was the largest region in the biologics market in 2024. Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3606

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Major Growth Driver Identified in 2025 Biologics Market: Personalized Medicine Fueling Growth In The Biologics Market here

News-ID: 4103239 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Biologic

Key Factor Supporting Global Biologic Imaging Reagents Market Development in 202 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Biologic Imaging Reagents Market Size By 2025? The market relating to biologic imaging reagents has experienced robust expansion recently, projecting an increase from its 2024 valuation of $18.41 billion to $20.1 billion by 2025, reflecting a compound annual growth rate (CAGR) of 9.1%. This upward
Key Influencer in the Biologic Imaging Reagents Market 2025: Chronic Disease Pre …
How Are the key drivers contributing to the expansion of the biologic imaging reagents market? As the prevalence of chronic diseases continues to rise, it is anticipated that the biologic imaging reagents market will enjoy substantial growth. Chronic diseases are those that persist for at least a year and necessitate sustained medical attention, often worsening over time. Biologic imaging reagents facilitate the visualisation of organs and affected structures, making it possible
Key Trends Shaping the Future Biologic Imaging Reagents Market From 2025-2034: I …
What Is the Estimated Market Size and Growth Rate for the Biologic Imaging Reagents Market? The biologic imaging reagents market has grown at a fast pace in recent years. It is set to expand from $18.41 billion in 2024 to $20.26 billion in 2025 at a CAGR of 10.0%. The growth in previous years can be attributed to the rising prevalence of chronic illnesses, increasing R&D investments, a shift towards personalized
Biologic Response Modifiers Market - Advancing Immunotherapy: Biologic Response …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Biologic Response Modifiers Market. Biologic Response Modifiers Market: https://www.growthplusreports.com/report/biologic-response-modifiers-market/9134 The Biologic Response Modifiers Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends that influence the
Nerve Biologic Products Market - Advancements in research and development for de …
The report presents an in-depth assessment of the Nerve Biologic Products Market including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles, and strategies. The report profiles the key players in the industry, along with a detailed analysis of their individual positions against the global landscape. The study conducts SWOT analysis to evaluate strengths and weaknesses
Biologic Microscope Market Global Insights and Demand 2020
Global Biologic Microscope Market research report published by market insight reports explores the current outlook in global and key regions from the perspective of Major Players, Countries, Product types and end industries. This report analyzes top players in the global market, and divides the Market into several parameters. This Biologic Microscope Market research report identifies the competitive landscape of industries to understand the competition at International level. This report study describes